Anne E Jensen

Title: The Innovative Contributions of Anne E. Jensen

Introduction

Anne E. Jensen is a prominent inventor based in Mill Creek, WA (US). She has made significant contributions to the field of immunology, particularly in the development of therapeutic antibodies. With a total of 2 patents to her name, her work focuses on enhancing T-cell function to combat cancer and other disorders.

Latest Patents

Jensen's latest patents include groundbreaking innovations in the realm of monoclonal antibodies. The first patent, titled "Anti-PD-L1 antibodies and methods of making and using thereof," provides anti-PD-L1 monoclonal antibodies, therapeutic compositions, and their applications in upregulating T-cell function. This innovation aims to enhance cell-mediated immune responses in the treatment of cancer and other T-cell dysfunctional disorders. The second patent, "Anti-PD-1 antibodies and methods of making and using thereof," similarly focuses on anti-PD-1 monoclonal antibodies and their therapeutic uses, further contributing to the fight against cancer.

Career Highlights

Throughout her career, Anne E. Jensen has worked with notable companies in the pharmaceutical industry. She has been associated with Baili-bio (Chengdu) Pharmaceutical Co., Ltd. and Systimmune, Inc. These experiences have allowed her to apply her innovative ideas in practical settings, leading to advancements in cancer treatment.

Collaborations

Jensen has collaborated with esteemed colleagues, including Brian Robert Kovacevich and Dong Xia. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of immunology.

Conclusion

Anne E. Jensen's contributions to the field of immunology through her innovative patents and collaborations highlight her dedication to advancing cancer treatment. Her work continues to inspire future innovations in therapeutic antibodies.